ETF Managers Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,587
| Closed | -$21K | – | 863 |
|
|
2022
Q1 | $21K | Buy |
14,587
+51
| +0.4% | +$73 | ﹤0.01% | 686 |
|
|
2021
Q4 | $38K | Sell |
14,536
-2,636
| -15% | -$6.89K | ﹤0.01% | 673 |
|
|
2021
Q3 | $54K | Buy |
17,172
+2,993
| +21% | +$9.41K | ﹤0.01% | 654 |
|
|
2021
Q2 | $52K | Buy |
14,179
+5,184
| +58% | +$19K | ﹤0.01% | 635 |
|
|
2021
Q1 | $29K | Sell |
8,995
-5,288
| -37% | -$17K | ﹤0.01% | 657 |
|
|
2020
Q4 | $50K | Sell |
14,283
-2,151
| -13% | -$7.53K | ﹤0.01% | 612 |
|
|
2020
Q3 | $57K | Buy |
16,434
+7,779
| +90% | +$27K | ﹤0.01% | 610 |
|
|
2020
Q2 | $40K | Buy |
+8,655
| New | +$40K | ﹤0.01% | 593 |
|